• SARS-CoV-2 ORF3a Q57H and Apoptosis

  2026-10-01

  The reference study shows that the SARS-CoV-2 ORF3a-Q57H variant can reduce pro-apoptotic signaling without substantially lowering total cellular ORF3a abundance. Its main contribution is to distinguish altered protein function and plasma-membrane distribution from simple loss of expression, providing a useful framework for dissecting viral control of host-cell death.

• CCG-1423: A Practical RhoA Inhibitor Workflow

  2026-09-30

  CCG-1423 is a mechanistically focused RhoA inhibitor for connecting MRTF-A nuclear import with proliferation, invasion, apoptosis, and barrier-function phenotypes. This guide translates its use into reproducible cell-based workflows while clearly separating established product biology from exploratory applications in viral signaling.

• TMEM16F in Kupffer Cells Protects Against Listeria

  2026-09-30

  The reference study identifies Kupffer cell-expressed TMEM16F as a central determinant of host protection during Listeria monocytogenes infection. Cell-specific mouse models show that this calcium-activated lipid scramblase preserves macrophage membrane integrity, limits liver inflammation, and helps maintain metabolic homeostasis.

• Fluconazole at the Host–Fungus Interface

  2026-09-29

  Fluconazole research can reveal more than ergosterol disruption when pharmacology is interpreted alongside mucosal antifungal defense. This guide connects 14α-demethylase inhibition with the METTL9–PRA1 zinc-acquisition pathway and shows how to design more informative Candida assays.

• Minocycline HCl for Retinal Microglia Assays

  2026-09-29

  Use Minocycline HCl as a pharmacological activity probe—not merely as an antibiotic—to test whether microglial regulation contributes to retinal amyloid clearance. This workflow connects 40-Hz flicker, MHC-II biology, Aβ burden, and functional readouts while highlighting controls for solubility, vehicle effects, and interpretation.

• Haloprogin: Practical Antifungal Workflows

  2026-09-28

  Haloprogin combines strong dermatophyte activity with measurable anti-yeast and selective Gram-positive antibacterial effects, making it useful for more than a single-organism screen. This guide translates legacy broth and topical infection-model data into reproducible MIC, MFC, formulation, and troubleshooting workflows.

• Cell Integrity Sets a Ploidy Limit in Budding Yeast

  2026-09-28

  Barker, Murray, and Bell show that budding yeast can reach 32–64C ploidy after repeated genome replication, but that cell-surface stress constrains further increases. Their experiments connect this limit to physical cell integrity and repression of ergosterol-biosynthesis genes, offering a framework for studying how genome expansion changes fungal cell physiology.

• Biotin-16-UTP for HCC RNA Assays

  2026-09-27

  Use Biotin-16-UTP to add an affinity handle to in vitro transcripts for RNA capture, detection, and interaction assays inspired by RNASEH1-AS1 research in hepatocellular carcinoma. A controlled labeling titration helps balance streptavidin capture against transcript yield and RNA function.

• Caspase Inhibition as a Translational Test of Mechanism

  2026-09-26

  Boc-D-FMK can help researchers test whether caspase activity contributes to cell death and inflammatory readouts. This article outlines how to use that intervention strategically, interpret it alongside a glioblastoma study of ATF5 and CYP2B6, and avoid treating pathway association as proof of causality.

• Panobinostat (LBH589): From HDAC Inhibition to ER Stress

  2026-09-25

  Panobinostat (LBH589) is a broad-spectrum HDAC inhibitor for investigating how chromatin changes intersect with proteostasis stress in cancer models. This article examines a preclinical multiple myeloma combination study and translates its findings into practical assay-design decisions without overstating biomarker or therapeutic claims.

• Itraconazole Workflows for Candida Biofilm Research

  2026-09-25

  Use Itraconazole to connect Candida susceptibility and biofilm experiments with a separate, well-defined CYP3A4 drug-interaction workflow. This practical guide translates a recent PP2A–autophagy study into testable assay choices while distinguishing reported findings from proposed experiments.

• Tioconazole: From Ergosterol Biology to Better Models

  2026-09-24

  Tioconazole offers translational researchers a mechanistically grounded way to probe fungal sterol biology. This article connects its antifungal action to practical assay design, while drawing a carefully bounded lesson from recent leukemia research: biological context can reshape molecular outcomes, but findings should not be transferred across systems without direct testing.

• Nystatin (Fungicidin): Applied Antifungal Workflows

  2026-09-24

  Use Nystatin (Fungicidin) to build interpretable Candida susceptibility and adhesion assays, then extend carefully into formulation research. This guide pairs practical bench workflows with troubleshooting and a clear boundary between antifungal evidence and nanoparticle findings from ocular research.

• HACC-TNF-α-VLPs Boost FMD Antigen Cross-Presentation

  2026-09-23

  This study reports HACC-TNF-α-virus-like particle nanoparticles designed to address a limitation of FMD VLP vaccines: weak CD8+ T-cell and mucosal responses. The findings link the formulation to HSP90-dependent antigen cross-presentation and stronger cellular and mucosal immune readouts in mice, supporting further evaluation as a vaccine-delivery strategy.

• DiscoveryProbe FDA-approved Drug Library: HTS Guide

  2026-09-23

  Build a practical antiviral screening workflow around a clinically annotated compound set, combining biochemical FRET with live-cell stress-granule analysis. The approach turns drug repositioning screening into a staged process that separates protease inhibition, cytotoxicity, and host-response effects.

527 records 1/36 page Next 12345 下5页 Last page